FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Abeona Gains Approval of Resubmitted Zevaskyn

[ Price : $8.95]

FDA approves Abeona Therapeutics Zevaskyn (prademagene zamikeracel) gene-modified cellular sheets, an autologous cell-based gene t...

Learn from Exer Labs Warning on AI Use: Attorneys

[ Price : $8.95]

Two Hogan Lovells attorneys discuss lessons medical device companies can learn about AI use from a recent FDA Warning Letter to Ex...

Trial Shows Value of Immunotherapy in Some Cancers

[ Price : $8.95]

A Memorial Sloan Kettering Cancer Center Phase 2 trial demonstrates the value of immunotherapy in MMRd genetic mutation cancers in...

No Broad FDA Reorganization Coming: Makary

[ Price : $8.95]

In a wide-ranging Inside Medicine Substack interview, FDA commissioner Martin Makary says there will be no broad reorganization at...

Senator Hawley Urges FDA Action on Mifepristone Study

[ Price : $8.95]

Senator Josh Hawley (R-Mo.) urges FDA commissioner Marty Makary to review a new study allegedly revealing greater safety risks tha...

Bladder Cancer Drug Meets Primary Endpoint: Pfizer

[ Price : $8.95]

Pfizer says the pivotal Phase 3 CREST trial of sasanlimab in combination with standard of care met its primary endpoint as an indu...

J&J Touts Bladder Cancer Data in Recent NDA

[ Price : $8.95]

J&J reports data from the Phase 2b SunRISe-1 study evaluating TAR-200, an intravesical gemcitabine releasing system, for patients ...

Novavax, HHS Clarify on Post-approval Covid Study

[ Price : $8.95]

Novavax and HHS clarify that FDA is requesting a post-approval study and not a clinical trial that must be conducted prior to appr...

Medtronic Files PMA for Hugo Urology Surgical Robot

[ Price : $8.95]

Medtronic files a PMA for its Hugo robotic-assisted surgery system for a urologic indication.

BlackfinBio Plans Gene Therapy Trial

[ Price : $8.95]

FDA clears BlackfinBio to conduct a Phase 1/2 clinical trial of its novel adeno-associated virus gene therapy, BFB-101, in childre...